Clinical Trials Logo

Subdural Hematoma, Non-acute clinical trials

View clinical trials related to Subdural Hematoma, Non-acute.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04700345 Active, not recruiting - Clinical trials for Subdural Hematoma, Non-acute

Managing Non-acute Subdural Hematoma Using Liquid Materials:a Chinese Randomized Trial of MMA Treatment

MAGIC-MT
Start date: March 21, 2021
Phase: N/A
Study type: Interventional

MAGIC-MT study is multi-center, prospective, randomized (1:1) controlled trial designed to show that additional MMA embolization with Onyx in patients with non-acute symptomatic subdural hematoma(SDH) results in reduced hematoma recurrence in surgically treated patients/ reduced hematoma progression in conservatively managed patients.